CECR2 gene inhibition prevents triple-negative breast cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.

Related Keywords

Qin Yan , Emily Henderson , Epigenetics Research Program , Breast Cancer Of Yale Center , Scientific Co , Yale Cancer Center , Science Translational , Associate Professor , Yale School , Scientific Co Director , Breast Cancer , Yale Cancer , Senior Study , Dancer , Cancer Treatment , Epigenetics , Gene , Hospital , Medicine , Olecule , Pathology , Research , Herapeutics , Humor ,